APO Research
Talk to an analyst

APO RESEARCH · REPORT

Follicle Stimulating Hormone

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Selected research

Market Outlook & Growth Opportunities

Global Follicle Stimulating Hormone Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchFollicle Stimulating Hormone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Follicle Stimulating Hormone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Follicle Stimulating Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Follicle Stimulating Hormone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Follicle Stimulating Hormone Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.

There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.

Read the full market overview

This report provides an overview of the global Follicle Stimulating Hormone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Follicle Stimulating Hormone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Follicle Stimulating Hormone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Follicle Stimulating Hormone market size, projected growth trends, production technologies, key applications, and end-use industries.

Follicle Stimulating Hormone Segment by Company

Merck Serono

MSD

IBSA

Ferring

Livzon

Techwell

GenSci

Gedeon Richter

Teva

Follicle Stimulating Hormone Segment by Type

Recombinant FSH

Urinary FSH

Follicle Stimulating Hormone Segment by Application

Infertility Treatment

Assisted Reproductive Technology

Follicle Stimulating Hormone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Follicle Stimulating Hormone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Follicle Stimulating Hormone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Follicle Stimulating Hormone significant trends, drivers, influence factors in global and regions.

6. To analyze Follicle Stimulating Hormone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Follicle Stimulating Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Follicle Stimulating Hormone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Follicle Stimulating Hormone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Follicle Stimulating Hormone industry.

Chapter 3: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Follicle Stimulating Hormone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Follicle Stimulating Hormone Industry Trends Table 2. Follicle Stimulating Hormone Industry Drivers Table 3. Follicle Stimulating Hormone Industry Opportunities and Challenges Table 4. Follicle Stimulating Hormone Industry Restraints Table 5. Global Follicle Stimulating Hormone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Follicle Stimulating Hormone Revenue Share by Company (2021-2026) Table 7. Global Follicle Stimulating Hormone Sales Volume by Company (k doses) & (2021-2026) Table 8. Global Follicle Stimulating Hormone Sales Volume Share by Company (2021-2026) Table 9. Global Follicle Stimulating Hormone Average Price (USD/dose) of Company (2021-2026) Table 10. Global Follicle Stimulating Hormone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Follicle Stimulating Hormone Key Company Manufacturing Base & Headquarters Table 12. Global Follicle Stimulating Hormone Company, Product Type & Application Table 13. Global Follicle Stimulating Hormone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Recombinant FSH Table 18. Significant Companies of Urinary FSH Table 19. Global Follicle Stimulating Hormone Sales Volume by Type 2021 VS 2025 VS 2032 (k doses) Table 20. Global Follicle Stimulating Hormone Sales Volume by Type (2021-2026) & (k doses) Table 21. Global Follicle Stimulating Hormone Sales Volume by Type (2027-2032) & (k doses) Table 22. Global Follicle Stimulating Hormone Sales Volume Share by Type (2021-2026) Table 23. Global Follicle Stimulating Hormone Sales Volume Share by Type (2027-2032) Table 24. Global Follicle Stimulating Hormone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Follicle Stimulating Hormone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Follicle Stimulating Hormone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Follicle Stimulating Hormone Sales Value Share by Type (2021-2026) Table 28. Global Follicle Stimulating Hormone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Infertility Treatment Table 30. Significant Companies of Assisted Reproductive Technology Table 31. Global Follicle Stimulating Hormone Sales Volume by Application 2021 VS 2025 VS 2032 (k doses) Table 32. Global Follicle Stimulating Hormone Sales Volume by Application (2021-2026) & (k doses) Table 33. Global Follicle Stimulating Hormone Sales Volume by Application (2027-2032) & (k doses) Table 34. Global Follicle Stimulating Hormone Sales Volume Share by Application (2021-2026) Table 35. Global Follicle Stimulating Hormone Sales Volume Share by Application (2027-2032) Table 36. Global Follicle Stimulating Hormone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Follicle Stimulating Hormone Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Follicle Stimulating Hormone Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Follicle Stimulating Hormone Sales Value Share by Application (2021-2026) Table 40. Global Follicle Stimulating Hormone Sales Value Share by Application (2027-2032) Table 41. Global Follicle Stimulating Hormone Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 42. Global Follicle Stimulating Hormone Sales by Region (2021-2026) & (k doses) Table 43. Global Follicle Stimulating Hormone Sales Market Share by Region (2021-2026) Table 44. Global Follicle Stimulating Hormone Sales by Region (2027-2032) & (k doses) Table 45. Global Follicle Stimulating Hormone Sales Market Share by Region (2027-2032) Table 46. Global Follicle Stimulating Hormone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Follicle Stimulating Hormone Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Follicle Stimulating Hormone Sales Value Share by Region (2021-2026) Table 49. Global Follicle Stimulating Hormone Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Follicle Stimulating Hormone Sales Value Share by Region (2027-2032) Table 51. Global Follicle Stimulating Hormone Market Average Price (USD/dose) by Region (2021-2026) Table 52. Global Follicle Stimulating Hormone Market Average Price (USD/dose) by Region (2027-2032) Table 53. Global Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (k doses) Table 54. Global Follicle Stimulating Hormone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 56. Global Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 57. Global Follicle Stimulating Hormone Sales by Country (2027-2032) & (k doses) Table 58. Global Follicle Stimulating Hormone Sales Market Share by Country (2027-2032) Table 59. Global Follicle Stimulating Hormone Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Follicle Stimulating Hormone Sales Value Market Share by Country (2021-2026) Table 61. Global Follicle Stimulating Hormone Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Follicle Stimulating Hormone Sales Value Market Share by Country (2027-2032) Table 63. Merck Serono Company Information Table 64. Merck Serono Business Overview Table 65. Merck Serono Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 66. Merck Serono Follicle Stimulating Hormone Product Portfolio Table 67. Merck Serono Recent Development Table 68. MSD Company Information Table 69. MSD Business Overview Table 70. MSD Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 71. MSD Follicle Stimulating Hormone Product Portfolio Table 72. MSD Recent Development Table 73. IBSA Company Information Table 74. IBSA Business Overview Table 75. IBSA Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 76. IBSA Follicle Stimulating Hormone Product Portfolio Table 77. IBSA Recent Development Table 78. Ferring Company Information Table 79. Ferring Business Overview Table 80. Ferring Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 81. Ferring Follicle Stimulating Hormone Product Portfolio Table 82. Ferring Recent Development Table 83. Livzon Company Information Table 84. Livzon Business Overview Table 85. Livzon Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 86. Livzon Follicle Stimulating Hormone Product Portfolio Table 87. Livzon Recent Development Table 88. Techwell Company Information Table 89. Techwell Business Overview Table 90. Techwell Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 91. Techwell Follicle Stimulating Hormone Product Portfolio Table 92. Techwell Recent Development Table 93. GenSci Company Information Table 94. GenSci Business Overview Table 95. GenSci Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 96. GenSci Follicle Stimulating Hormone Product Portfolio Table 97. GenSci Recent Development Table 98. Gedeon Richter Company Information Table 99. Gedeon Richter Business Overview Table 100. Gedeon Richter Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 101. Gedeon Richter Follicle Stimulating Hormone Product Portfolio Table 102. Gedeon Richter Recent Development Table 103. Teva Company Information Table 104. Teva Business Overview Table 105. Teva Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 106. Teva Follicle Stimulating Hormone Product Portfolio Table 107. Teva Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Follicle Stimulating Hormone Distributors List Table 111. Follicle Stimulating Hormone Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Follicle Stimulating Hormone Product Image Figure 2. Global Follicle Stimulating Hormone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Follicle Stimulating Hormone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Follicle Stimulating Hormone Sales (2021-2032) & (k doses) Figure 5. Global Follicle Stimulating Hormone Sales Average Price (USD/dose) & (2021-2032) Figure 6. Global Follicle Stimulating Hormone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Recombinant FSH Image Figure 10. Urinary FSH Image Figure 11. Global Follicle Stimulating Hormone Sales Volume by Type (2021 VS 2025 VS 2032) & (k doses) Figure 12. Global Follicle Stimulating Hormone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Follicle Stimulating Hormone Sales Volume Share by Type (2021-2032) Figure 14. Global Follicle Stimulating Hormone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Follicle Stimulating Hormone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Follicle Stimulating Hormone Sales Value Share by Type (2021-2032) Figure 17. Infertility Treatment Image Figure 18. Assisted Reproductive Technology Image Figure 19. Global Follicle Stimulating Hormone Sales Volume by Application (2021 VS 2025 VS 2032) & (k doses) Figure 20. Global Follicle Stimulating Hormone Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Follicle Stimulating Hormone Sales Volume Share by Application (2021-2032) Figure 22. Global Follicle Stimulating Hormone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Follicle Stimulating Hormone Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Follicle Stimulating Hormone Sales Value Share by Application (2021-2032) Figure 25. Global Follicle Stimulating Hormone Sales by Region: 2021 VS 2025 VS 2032 (k doses) Figure 26. Global Follicle Stimulating Hormone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Follicle Stimulating Hormone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Follicle Stimulating Hormone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Follicle Stimulating Hormone Sales Value (2021-2032) & (US$ Million) Figure 30. North America Follicle Stimulating Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Follicle Stimulating Hormone Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Follicle Stimulating Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Follicle Stimulating Hormone Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Follicle Stimulating Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Follicle Stimulating Hormone Sales Value (2021-2032) & (US$ Million) Figure 36. South America Follicle Stimulating Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Follicle Stimulating Hormone Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Follicle Stimulating Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Follicle Stimulating Hormone Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Follicle Stimulating Hormone Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant FSH
  • Urinary FSH
Applications
  • Infertility Treatment
  • Assisted Reproductive Technology
Companies covered
  • Merck Serono
  • MSD
  • IBSA
  • Ferring
  • Livzon
  • Techwell
  • GenSci
  • Gedeon Richter
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Follicle Stimulating Hormone Sales Value (2021-2032)
  4. 1.2.2 Global Follicle Stimulating Hormone Sales Volume (2021-2032)
  5. 1.2.3 Global Follicle Stimulating Hormone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Follicle Stimulating Hormone Market Dynamics
  1. 2.1 Follicle Stimulating Hormone Industry Trends
  2. 2.2 Follicle Stimulating Hormone Industry Drivers
  3. 2.3 Follicle Stimulating Hormone Industry Opportunities and Challenges
  4. 2.4 Follicle Stimulating Hormone Industry Restraints
3 Follicle Stimulating Hormone Market by Company
  1. 3.1 Global Follicle Stimulating Hormone Company Revenue Ranking in 2025
  2. 3.2 Global Follicle Stimulating Hormone Revenue by Company (2021-2026)
  3. 3.3 Global Follicle Stimulating Hormone Sales Volume by Company (2021-2026)
  4. 3.4 Global Follicle Stimulating Hormone Average Price by Company (2021-2026)
  5. 3.5 Global Follicle Stimulating Hormone Company Ranking (2024-2026)
  6. 3.6 Global Follicle Stimulating Hormone Company Manufacturing Base and Headquarters
  7. 3.7 Global Follicle Stimulating Hormone Company Product Type and Application
  8. 3.8 Global Follicle Stimulating Hormone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Follicle Stimulating Hormone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Follicle Stimulating Hormone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Follicle Stimulating Hormone Market by Type
  1. 4.1 Follicle Stimulating Hormone Type Introduction
  2. 4.1.1 Recombinant FSH
  3. 4.1.2 Urinary FSH
  4. 4.2 Global Follicle Stimulating Hormone Sales Volume by Type
  5. 4.2.1 Global Follicle Stimulating Hormone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Follicle Stimulating Hormone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Follicle Stimulating Hormone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Follicle Stimulating Hormone Sales Value by Type
  9. 4.3.1 Global Follicle Stimulating Hormone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Follicle Stimulating Hormone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Follicle Stimulating Hormone Sales Value Share by Type (2021-2032)
5 Follicle Stimulating Hormone Market by Application
  1. 5.1 Follicle Stimulating Hormone Application Introduction
  2. 5.1.1 Infertility Treatment
  3. 5.1.2 Assisted Reproductive Technology
  4. 5.2 Global Follicle Stimulating Hormone Sales Volume by Application
  5. 5.2.1 Global Follicle Stimulating Hormone Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Follicle Stimulating Hormone Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Follicle Stimulating Hormone Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Follicle Stimulating Hormone Sales Value by Application
  9. 5.3.1 Global Follicle Stimulating Hormone Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Follicle Stimulating Hormone Sales Value by Application (2021-2032)
  11. 5.3.3 Global Follicle Stimulating Hormone Sales Value Share by Application (2021-2032)
6 Follicle Stimulating Hormone Regional Sales and Value Analysis
  1. 6.1 Global Follicle Stimulating Hormone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Follicle Stimulating Hormone Sales by Region (2021-2032)
  3. 6.2.1 Global Follicle Stimulating Hormone Sales by Region: 2021-2026
  4. 6.2.2 Global Follicle Stimulating Hormone Sales by Region (2027-2032)
  5. 6.3 Global Follicle Stimulating Hormone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Follicle Stimulating Hormone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Follicle Stimulating Hormone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Follicle Stimulating Hormone Sales Value by Region (2027-2032)
  9. 6.5 Global Follicle Stimulating Hormone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Follicle Stimulating Hormone Sales Value (2021-2032)
  12. 6.6.2 North America Follicle Stimulating Hormone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Follicle Stimulating Hormone Sales Value (2021-2032)
  15. 6.7.2 Europe Follicle Stimulating Hormone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Follicle Stimulating Hormone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Follicle Stimulating Hormone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Follicle Stimulating Hormone Sales Value (2021-2032)
  21. 6.9.2 South America Follicle Stimulating Hormone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Follicle Stimulating Hormone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Follicle Stimulating Hormone Sales Value Share by Country, 2025 VS 2032
7 Follicle Stimulating Hormone Country-level Sales and Value Analysis
  1. 7.1 Global Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Follicle Stimulating Hormone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Follicle Stimulating Hormone Sales by Country (2021-2032)
  4. 7.3.1 Global Follicle Stimulating Hormone Sales by Country (2021-2026)
  5. 7.3.2 Global Follicle Stimulating Hormone Sales by Country (2027-2032)
  6. 7.4 Global Follicle Stimulating Hormone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Follicle Stimulating Hormone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Follicle Stimulating Hormone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Follicle Stimulating Hormone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Follicle Stimulating Hormone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Follicle Stimulating Hormone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Serono
  2. 8.1.1 Merck Serono Company Information
  3. 8.1.2 Merck Serono Business Overview
  4. 8.1.3 Merck Serono Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
  6. 8.1.5 Merck Serono Recent Developments
  7. 8.2 MSD
  8. 8.2.1 MSD Company Information
  9. 8.2.2 MSD Business Overview
  10. 8.2.3 MSD Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MSD Follicle Stimulating Hormone Product Portfolio
  12. 8.2.5 MSD Recent Developments
  13. 8.3 IBSA
  14. 8.3.1 IBSA Company Information
  15. 8.3.2 IBSA Business Overview
  16. 8.3.3 IBSA Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
  18. 8.3.5 IBSA Recent Developments
  19. 8.4 Ferring
  20. 8.4.1 Ferring Company Information
  21. 8.4.2 Ferring Business Overview
  22. 8.4.3 Ferring Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
  24. 8.4.5 Ferring Recent Developments
  25. 8.5 Livzon
  26. 8.5.1 Livzon Company Information
  27. 8.5.2 Livzon Business Overview
  28. 8.5.3 Livzon Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
  30. 8.5.5 Livzon Recent Developments
  31. 8.6 Techwell
  32. 8.6.1 Techwell Company Information
  33. 8.6.2 Techwell Business Overview
  34. 8.6.3 Techwell Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
  36. 8.6.5 Techwell Recent Developments
  37. 8.7 GenSci
  38. 8.7.1 GenSci Company Information
  39. 8.7.2 GenSci Business Overview
  40. 8.7.3 GenSci Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GenSci Follicle Stimulating Hormone Product Portfolio
  42. 8.7.5 GenSci Recent Developments
  43. 8.8 Gedeon Richter
  44. 8.8.1 Gedeon Richter Company Information
  45. 8.8.2 Gedeon Richter Business Overview
  46. 8.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
  48. 8.8.5 Gedeon Richter Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Follicle Stimulating Hormone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Teva Follicle Stimulating Hormone Product Portfolio
  54. 8.9.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Follicle Stimulating Hormone Value Chain Analysis
  2. 9.1.1 Follicle Stimulating Hormone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Follicle Stimulating Hormone Sales Mode & Process
  6. 9.2 Follicle Stimulating Hormone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Follicle Stimulating Hormone Distributors
  9. 9.2.3 Follicle Stimulating Hormone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst